证券日报网12月11日讯金达威在12月5日、12月8日、12月10日回答调研者提问时表示，公司将持续加强 旗下保健品品牌Doctor'sBest多特倍斯在国内市场的营销，依托品牌的国际化基因与集团的全产业链优 势，全力巩固、提升辅酶Q10、镁片、抗衰系列等优势产品的市场渗透率，同时加大潜力产品的推广力 度，通过加强团队建设、调整考核目标、增加营销投放、开发适销产品等途径，全面提升品牌在国内市 场的认知度与影响力；同时，公司将稳步推进国内保健品"金乐心"等品牌的建设与价值塑造工作，进一 步完善品牌矩阵布局。 （文章来源：证券日报） ...

编号：20251210 | | ☑ 特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动 类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 （） 君和资本 国源信达 博道基金 安信基金 博时基金 | | | 华夏基金 中信证券 财通证券 中金资管 羊角基金 | | | 首创自营 安信基金 兴证资管 上银基金 瑞众保险 | | | 浦银安盛 方正资管 明河投资 中银基金 紫金信托 | | | 宏利基金 银华基金 黄河财险 禾丰正则资管 | | | 光大证券资管 国寿安保基金 汇添富基金 LMR | | | 溁德资本 安通基金 宁波知远投资 | | 参与单位名称或 | 深圳蓝马资本管理公司 | | 人员姓名 | 深圳北斗星太空融投资公司 | | | 西安金本科技实业有限公司 | | | 深圳国安保证担保有限公司 | | | 广东臻远私募基金管理有限公司 | | | 晋江泉智私募基金管理有限公司 | | | 珠海市横琴天勤资产管理有限公司 | | | 湖南汇智融达私募基金管理有限公司 | | 时间 | 2025 年 12 ...

Group 1: Overall Business Performance - In the first half of 2025, the company's total revenue reached 17.28 billion yuan, a 13.46% increase compared to the same period last year [2] - The net profit attributable to shareholders was 90.12 million yuan, reflecting a 2.47% growth year-on-year [2] Group 2: Nutritional Raw Materials Business - The company specializes in the large-scale production of products such as Coenzyme Q10, DHA, ARA, NMN, and Vitamin K2, among others [3] - Coenzyme Q10 holds the largest global market share, with a significant increase in gross margin due to production scale effects and technological improvements [3] - The company is investing in new product development using synthetic biology and microbial fermentation technologies [3] Group 3: Coenzyme Q10 Business - Coenzyme Q10 is increasingly recognized for its health benefits, leading to a growing market demand, particularly in China due to aging population and upgraded health awareness [3] - The company is the largest global producer of Coenzyme Q10, exporting to numerous countries and regions [3] - Expansion plans are in place to meet the rising market demand and strengthen the company's leading position in the industry [3] Group 4: Nutritional Supplements Business - The company owns several brands, including Doctor's Best and Zipfizz, with production services provided by its U.S. subsidiary, VitaBest [4] - Sales of Doctor's Best and Zipfizz experienced a decline in the first half of 2025 due to inventory control and purchasing adjustments by downstream customers [5] - The company is focusing on brand building and enhancing marketing efforts to improve sales channels and brand influence [5] Group 5: Domestic Nutritional Supplements Business - The domestic market for nutritional supplements is primarily served through online channels like Tmall and JD.com, with growth driven by the increasing demand for cross-border e-commerce [5] - The company aims to enhance operational efficiency and expand its market share in domestic self-owned brands [5]